Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Theramex pioneers new treatment for post-menopausal women

September 24, 2021 Medical Communications

Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of …
News

Eurazeo set to become leading investor in Kurma Partners

September 24, 2021 Medical Communications

Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology …
News

AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients

September 24, 2021 Medical Communications

The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic …
News
az

AstraZeneca and VaxEquity to collaborate on saRNA platform

September 24, 2021 Medical Communications

AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the development …
News

CGT Catapult and Quell Therapeutics enter manufacturing collaboration

September 24, 2021 Medical Communications

CGT Catapult and Quell Therapeutics have announced a collaboration to facilitate an expanded manufacturing footprint focusing on the manufacturing capacity …
News

Government report finds serious overprescription issues in England

September 22, 2021 Medical Communications, Research and Development

A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …
News

J&J: Second COVID shot boosts effectiveness by 94%

September 22, 2021 Medical Communications, Research and Development

Johnson & Johnson have released data showing that a second dose of their one shot COVID-19 vaccine boosts protection from …
News

ONS data shows long COVID less common than feared

September 17, 2021 Medical Communications

New data released by the Office for National Statistics (ONS) reveal that only one in 40 people with coronavirus goes …
News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021 Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …
News

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021 Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …
News

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021 Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …
News

Menstrual changes after COVID jab must be investigated, says leading immunologist

September 16, 2021 Medical Communications

Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …
News

COVID deaths among fully vaccinated rare, ONS data finds

September 15, 2021 Medical Communications, Research and Development

New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …
News

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021 Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …
News

Israeli survey finds 1 in 10 children have long COVID

September 14, 2021 Medical Communications, Research and Development

An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025